Optimal Duration of Anticoagulation After Venous Thromboembolism

被引：21
作者：
Goldhaber, Samuel Z. [1 ]
Piazza, Gregory [1 ]
机构：
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Venous Thromboembolism Res Grp,Cardiovasc Med Div, Boston, MA 02115 USA
来源：
CIRCULATION | 2011年 / 123卷 / 06期
关键词：
anticoagulants; deep vein thrombosis; pulmonary embolism; thromboembolism; INTENSITY WARFARIN THERAPY; DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; LONG-TERM; RISK-FACTORS; PREVENTION; RECURRENCE;
D O I：
10.1161/CIRCULATIONAHA.110.970822
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：664 / 667
页数：4
相关论文
共 21 条
[1]   Elevated d-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis [J].
Bruinstroop, E. ;
Klok, F. A. ;
Van de Ree, M. A. ;
Oosterwijk, F. L. ;
Huisman, M. V. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (04) :611-618
[2]   Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism [J].
Eichinger, S ;
Weltermann, A ;
Minar, E ;
Stain, M ;
Schönauer, V ;
Schneider, B ;
Kyrle, PA .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (01) :92-96
[3]   Overweight, obesity, and the risk of recurrent venous thromboembolism [J].
Eichinger, Sabine ;
Hron, Gregor ;
Bialonczyk, Christine ;
Hirschl, Mirko ;
Minar, Erich ;
Wagner, Oswald ;
Heinze, Georg ;
Kyrle, Paul A. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (15) :1678-1683
[4]   High-density lipoprotein and the risk of recurrent venous thromboembolism [J].
Eichinger, Sabine ;
Pecheniuk, Natalie M. ;
Hron, Gregor ;
Deguchi, Hiroshi ;
Schemper, Michael ;
Kyrle, Paul A. ;
Griffin, John H. .
CIRCULATION, 2007, 115 (12) :1609-1614
[5]   Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism The Vienna Prediction Model [J].
Eichinger, Sabine ;
Heinze, Georg ;
Jandeck, Lisanne M. ;
Kyrle, Paul A. .
CIRCULATION, 2010, 121 (14) :1630-1636
[6]   Predictors of recurrence after deep vein thrombosis and pulmonary embolism -: A population-based cohort study [J].
Heit, JA ;
Mohr, DN ;
Silverstein, MD ;
Petterson, TM ;
O'Fallon, WM ;
Melton, LJ .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (06) :761-768
[7]   Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism [J].
Kearon, C ;
Ginsberg, JS ;
Kovacs, MJ ;
Anderson, DR ;
Wells, P ;
Julian, JA ;
MacKinnon, B ;
Weitz, JI ;
Crowther, MA ;
Dolan, S ;
Turpie, AG ;
Geerts, W ;
Solymoss, S ;
van Nguyen, P ;
Demers, C ;
Kahn, SR ;
Kassis, J ;
Rodger, M ;
Hambleton, J ;
Gent, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (07) :631-639
[8]   Antithrombotic therapy for venous thromboembolic disease [J].
Kearon, Clive ;
Kahn, Susan R. ;
Agnelli, Giancarlo ;
Goldhaber, Samuel ;
Raskob, Gary E. ;
Comerota, Anthony J. .
CHEST, 2008, 133 (06) :454S-545S
[9]   The risk of recurrent venous thromboembolism in men and women [J].
Kyrle, PA ;
Minar, E ;
Bialonczyk, C ;
Hirschl, M ;
Weltermann, A ;
Eichinger, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2558-2563
[10]   Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer [J].
Lee, AYY ;
Levine, MN ;
Baker, RI ;
Bowden, C ;
Kakkar, AK ;
Prins, M ;
Rickles, FR ;
Julian, JA ;
Haley, S ;
Kovacs, MJ ;
Gent, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :146-153
123